Product Description - Covid-19 SARS-CoV-2 Saliva Antigen Rapid Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 Saliva antigen (Ag) in human oropharyngeal (OP), nasal (NS), nasopharygeal (NP) swab, saliva or gargled water specimens from individuals who meet Covid-19 clinical criteria.
Made in Canada
Health Canada approved
CE Mark and ISO certified
The product has proven to have 100% Specificity and 96% Sensitivety
Stock availabity: 2 Million tests/kit in Canada
Production: up to 5 Million tests/kit weekly
The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point of Care i.e., in patient care setting. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patientâ??s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The Rapid Responseâ?¢ COVID-19 Antigen Rapid Test Device is for use at the Point of Care for professional use only.
PRODUCT INFORMATION:
Product: Rapid Respose
Sample: Nasal / Nasopharyngeal secretions
Format: Cassette
Quantity: 25 Tests/Kit per box
Time to result: 15 minutes
Storage Condition: 2-30 C/36-86 F
Test Principle: Immunochromatographic Assay
CONTENTS - Individually packed test devices
Extraction Buffer
Extraction tube
Nozzle with filter
Tube stand
Individually packed swabs
Package Insert
1702 Rapid Test Kits Suppliers
Short on time? Let Rapid Test Kits sellers contact you.
mLab / m-screen Corona Antigen Test
Simple nasal swap* or nasopharyngeal swab** / Under 30 minutes / Sensitivity 98.32%** and 97.25%* / TCID50 115 / In stock in Germany / CE IVD marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute / German Manufacturer / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
Laihe / Novel Corona Antigen Test
Nasopharyngeal swab / under 30 minutes / Sensitivity 95.07% / CE marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute and IVD / box of 100 / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
Nal von minden / dedico plus
Simple nasal swap or nasopharyngeal swab / under 30 minutes / Sensitivity 97.10% / TCID50 75.5 / CE IVD marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute / box of 100 / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
Joysbio Saliva Rapid Test Kit - Saliva Test Kit for public use / under 30 minutes / Sensitivity 95.10% / TCID50 320 / CE IVD marked for public use / In stock in Germany
Price 6.5 EUR + VAT
We send a POL after receiving the LOI.
We deliver in Europe only.
Only for Hospitals.
More information?
The new VivaDiag SARS-CoV-2 Ag Rapid Test is for the rapid, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in human nasal swab,oropharyngeal swab or nasopharyngeal swab specimen. The test is for in vitro diagnostic use only.
Special features:
For nasal or throat swab samples
CE marked
Professional Use Only
High Sensitivity
Short Turnout Time
High Specificity
Test Principle: Colloidal gold
Sample Type: Nasal swab, oropharyngeal swab or nasopharyngeal swab
Sample Volume: 60 L
Test Time: 15 min
Rapid tests available in stock in our deposits in Bucharest . Contact us to send you prices and certifications . OTG . You are welcome in our deposits to inspect our products .
A rapid test for the qualitative detection of novel coronavirus antigens in nasal, Nasopharyngeal (NP) swab & Oropharyngeal (OP) swab.
The S2 Covid-19 Rapid Antigen Test Kit (swab) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in Nasal swab, Nasopharyngeal swab (NP) and Oropharyngeal swab (OP), using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronavirus antigen.
This antigen test is suitable for the qualitative detection of novel coronavirus in Saliva/Sputum/Stool/NP Swab/OP Swab samples (all methods in single test). Result in 15mins
The product is based on the principle of antigen-antibody reaction and immunoassay technique. The test device contains colloidal gold labeled SARS-CoV-2 recombinant protein, mouse-anti human IgG antibody immobilized in G test area, mouse-anti human IgM antibody immobilized in M test area and the corresponding antibody in quality control area (C).
During the test, when the SARS-CoV-2 IgM antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgM antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. The conjugates migrate upward through capillary effect and would be captured by mouse-anti human IgM antibody immobilized in M test area subsequently and this produces a purple-red band appears in the M test area. When the SARS-CoV-2 IgG antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgG antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. Theconjugates migrate upward through capillary effect and would be captured by mouse-anti human IgG antibody immobilized in G test area subsequently and this produces a purple-red band appears in the G test area. If it is a negative sample, there is not a purple-red band appeared in the M and G test area. Regardless of the presence or absence of the SARS-CoV-2 antibody in the sample, a purple-red band will appear in the quality control area (C). The purple-red band in the quality control area (C) is a criterion for judging whether there is enough sample and whether the chromatography process is normal. It also serves as the internal control standard for reagents.
Antigen Rapid Covid-19 Test Kit Medakit.
Rapid diagnosis tests for Covid-19 infections (10 minutes).
Cassette 40 test/kit.
Main compound from Germany, assembly in China.
Certifications : FDA - MOFCOM - CE - ANVISA - TGA - ISO13485 - ISP - CNR (Institut Pasteur)
SKU: 4314-25
EAN: 4250415677038
clinical specificity = 100 %
clinical Sensitivity = 98,5 %
BfArM approval
fast and reliable test results in only 15 minutes
can be performed with naso- and oropharyngeal samples
all test components are included
1702 Rapid Test Kits Suppliers
Short on time? Let Rapid Test Kits sellers contact you.
